Thomas Jefferson University

Jefferson Digital Commons
Rothman Institute Faculty Papers

Rothman Institute

1-2-2013

The influence of obesity on the outcome of treatment of lumbar
disc herniation: analysis of the Spine Patient Outcomes Research
Trial (SPORT).
Jeffrey A Rihn
Thomas Jefferson University Hospital, Rothman Institute

Mark Kurd
Thomas Jefferson University Hospital, Rothman Institute

Alan S Hilibrand
Thomas Jefferson University Hospital, Rothman Institute

Jon Lurie
Dartmouth-Hitchcock
Medical
Center
Follow this and additional
works
at: https://jdc.jefferson.edu/rothman_institute

Wenyan
Part ofZhao
the Orthopedics Commons

Let us know how access to this document benefits you
Dartmouth-Hitchcock Medical Center

See
next page forCitation
additional authors
Recommended

Rihn, Jeffrey A; Kurd, Mark; Hilibrand, Alan S; Lurie, Jon; Zhao, Wenyan; Albert, Todd; and
Weinstein, James, "The influence of obesity on the outcome of treatment of lumbar disc
herniation: analysis of the Spine Patient Outcomes Research Trial (SPORT)." (2013). Rothman
Institute Faculty Papers. Paper 29.
https://jdc.jefferson.edu/rothman_institute/29
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Rothman Institute Faculty Papers by an authorized administrator of the Jefferson Digital
Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

Authors
Jeffrey A Rihn, Mark Kurd, Alan S Hilibrand, Jon Lurie, Wenyan Zhao, Todd Albert, and James Weinstein

This article is available at Jefferson Digital Commons: https://jdc.jefferson.edu/rothman_institute/29

1
C OPYRIGHT Ó 2013

BY

T HE J OURNAL

OF

B ONE

AND J OINT

S URGERY, I NCORPORATED

The Influence of Obesity on the Outcome of
Treatment of Lumbar Disc Herniation
Analysis of the Spine Patient Outcomes Research Trial (SPORT)
Jeffrey A. Rihn, MD, Mark Kurd, MD, Alan S. Hilibrand, MD, Jon Lurie, MD, MS, Wenyan Zhao, PhD,
Todd Albert, MD, and James Weinstein, DO, MS
Investigation performed at the Rothman Institute, Thomas Jefferson University Hospital, Philadelphia,
Pennsylvania, and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Background: Questions remain as to the effect that obesity has on patients managed for symptomatic lumbar disc
herniation. The purpose of this study was to determine if obesity affects outcomes following the treatment of symptomatic
lumbar disc herniation.
Methods: An as-treated analysis was performed on patients enrolled in the Spine Patient Outcomes Research Trial for
the treatment of lumbar disc herniation. A comparison was made between patients with a body mass index of <30 kg/m2
(nonobese) (n = 854) and those with a body mass index of ‡30 kg/m2 (obese) (n = 336). Baseline patient demographic
and clinical characteristics were documented. Primary and secondary outcomes were measured at baseline and at regular
follow-up time intervals up to four years. The difference in improvement from baseline between operative and nonoperative
treatment was determined at each follow-up period for both groups.
Results: At the time of the four-year follow-up evaluation, improvements over baseline in primary outcome measures were
significantly less for obese patients as compared with nonobese patients in both the operative treatment group (Short Form36 physical function, 37.3 compared with 47.7 points [p < 0.001], Short Form-36 bodily pain, 44.2 compared with 50.0
points [p = 0.005], and Oswestry Disability Index, 233.7 compared with 240.1 points [p < 0.001]) and the nonoperative
treatment group (Short Form-36 physical function, 23.1 compared with 32.0 points [p < 0.001] and Oswestry Disability
Index, 221.4 compared with 226.1 points [p < 0.001]). The one exception was that the change from baseline in terms of
the Short Form-36 bodily pain score was statistically similar for obese and nonobese patients in the nonoperative treatment
group (30.9 compared with 33.4 points [p = 0.39]). At the time of the four-year follow-up evaluation, when compared with
nonobese patients who had been managed operatively, obese patients who had been managed operatively had significantly
less improvement in the Sciatica Bothersomeness Index and the Low Back Pain Bothersomeness Index, but had no
significant difference in patient satisfaction or self-rated improvement. In the present study, 77.5% of obese patients and
86.9% of nonobese patients who had been managed operatively were working a full or part-time job. No significant differences were observed in the secondary outcome measures between obese and nonobese patients who had been managed
nonoperatively. The benefit of surgery over nonoperative treatment was not affected by body mass index.
continued
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Conclusions: Obese patients realized less clinical benefit from both operative and nonoperative treatment of lumbar
disc herniation. Surgery provided similar benefit over nonoperative treatment in obese and nonobese patients.
Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

O

besity, commonly defined as a body mass index (BMI)
of ‡30 kg/m2, affects one-third of the adult U.S. population, accounts for 10% of all U.S. health-care expenditures, and is associated with numerous clinical sequelae1-4. The
impact of obesity on musculoskeletal and spinal disease, including
low back pain, facet arthritis, and degenerative disc disease, has
been well documented5-11. Although some studies have reported
increased postoperative complications after spine surgery, multiple studies have demonstrated a beneficial effect from surgery on
obese patients with the appropriate indications12-15.
Despite the recognized importance of the effect of obesity
on musculoskeletal conditions, the link between obesity and
lumbar disc herniation has received little attention. It is difficult
to draw conclusions from prior studies on this topic, as the data
are somewhat contradictory14,16-21.
Because of the lack of clarity on the role that obesity plays in
patients with lumbar disc herniation, we sought to use the Spine
Patient Outcomes Research Trial (SPORT) database to further
explore this issue22. The purpose of this study was to determine if
obesity affects outcomes following the treatment, both operative
and nonoperative, of lumbar disc herniation. The hypothesis of
the current study was that obese patients would have less clinical
improvement over baseline function than nonobese patients after
treatment for symptomatic lumbar disc herniation.
Materials and Methods
Study Design

E

nrollment in SPORT was conducted at thirteen multidisciplinary spine
practices in eleven states across the United States. The study design and
22
methods of SPORT have been previously published .

Patients
The SPORT protocol was approved by the human subject committees at each
participating center. Criteria for inclusion in the lumbar disc herniation cohort
were age greater than eighteen years, radicular pain for at least six weeks with a
positive nerve root tension sign and/or neurological deficit, and a confirmatory
cross-sectional imaging study demonstrating intervertebral disc herniation at a
level and side corresponding to their symptoms. Exclusion criteria included
cauda equina syndrome, a progressive neurological deficit, malignancy, scoliosis of >15°, herniation cephalad to L2, prior back surgery, and other established contraindications to elective surgery.

Study Interventions
Patients were offered participation in either a randomized cohort or a concurrent
observational cohort. Those in the randomized cohort received computergenerated random treatment assignments. Those in the observational cohort
chose their treatment with their physician. Patients in the operative treatment
group were designated to undergo lumbar discectomy. Patients in the nonoperative treatment group were managed with minimum nonsurgical treatment,
which included active physical therapy, education, counseling with home exercise
instruction, and nonsteroidal anti-inflammatory drugs if tolerated. Additionally,

patients could receive any therapies above the minimum required protocol that
were deemed appropriate by their physician. Because of the extensive crossover in
the randomized cohort in which some patients who had been randomized to the
nonoperative treatment group instead received operative treatment and vice
versa, and because of the similar baseline characteristics and outcomes when
comparing the randomized and observational cohorts when analyzed by treatment, the two groups were combined in this as-treated analysis.

Study Measures
Data used in this study were obtained from patient questionnaires completed at
baseline, six weeks, three months, six months, one year, two years, three years, and
four years after enrollment or surgery. The primary outcome measures included
23
the physical function and bodily pain domains of the Short Form-36 (SF-36)
and the American Academy of Orthopaedic Surgeons MODEMS (Musculoskeletal Outcomes Data Evaluation and Management System) version of the
24
Oswestry Disability Index . The secondary outcome measures included patient
self-reported improvement, work status, and satisfaction with current symptoms
25
and with treatment . Symptom severity was measured by means of the Low Back
26-28
Pain Bothersomeness Index and the Sciatica Bothersomeness Index
. The SF36 scales range from 1 to 100 points, with higher scores indicating less severe
symptoms. The Oswestry Disability Index also ranges from 0 to 100 points, but
higher scores indicate more severe symptoms. The Sciatica Bothersomeness Index
ranges from 0 to 24 points, and the Low Back Pain Bothersomeness Index ranges
from 0 to 6 points; in these indices, higher scores indicate more severe symptoms.

Statistical Analysis
The primary analyses compared changes in the clinical outcome measures from
baseline as a function of the patient BMI at the time of enrollment in the study.
BMI was calculated as the weight in kilograms divided by the height in meters
29
squared according to National Institutes of Health (NIH) criteria . For study
purposes, the patients were divided into two groups on the basis of BMI: nonobese (BMI, <30 kg/m2) and obese (BMI, ‡30 kg/m2). The baseline characteristics of nonobese and obese patients were compared with use of a chi-square test
for categorical variables and a t test for continuous variables. The primary
analyses compared operative and nonoperative treatments with use of changes
from baseline at each follow-up evaluation, with a mixed effects longitudinal
regression model, including a random individual effect to account for the correlation between repeated measurements within individuals. A formal interaction
term of the treatment and obesity was in the model for comparing the treatment
effect in the subgroups. Because of the crossover, analyses were based on treatments actually received in the combined randomized and observational cohorts.
In these as-treated analyses, the treatment indicator was a time-varying covariate,
allowing for variable times of surgery. Times were measured from the beginning
of treatment, which was the time of surgery for the operative treatment group
and the time of enrollment for the nonoperative treatment group. Therefore, all
changes from baseline prior to surgery were included in the estimates of the
nonoperative treatment effect. After surgery, changes were assigned to the operative treatment group with follow-up evaluations measured from the date of
surgery. Repeated measures of outcomes were used as the dependent variables,
and treatment received was included as a time-varying covariate.
To adjust for potential confounding, baseline variables associated with
missing data or treatment received were included as adjusting covariates in
longitudinal regression models (marital status, smoking status, compensation,
herniation location, working status, depression, other comorbidities, self-rated
health trend, duration of the most recent episode, or treatment preference). In
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TABLE I Operative Treatments, Complications, and Events
Variables

Nonobese Cohort

Obese Cohort

BMI (kg/m2)

<30

‡30

Lumbar disc herniation* (no. of patients)

854

336

11 (2%)
20 (4%)
202 (36%)
323 (58%)

3 (1%)
7 (3%)
110 (44%)
130 (52%)

0.65
0.75
0.026
0.21

Operation time‡ (min)

72.3 ± 33.5

86.5 ± 43.5

<0.001

Blood loss‡ (mL)

56.1 ± 90.8

83.2 ± 121.4

<0.001

Discectomy level† (no. of patients)
L2-L3
L3-L4
L4-L5
L5-S1

Blood replacement† (no. of patients)
Intraoperative replacement
Postoperative transfusion

P Value

0.76
5 (1%)
0 (0%)

Length of stay‡ (d)
Intraoperative complications§ (no. of patients)
Dural tear or spinal fluid leak
Nerve root injury
Other
None
Postoperative complications or events# (no. of patients)
Nerve root injury
Wound hematoma
Wound infection
Other
None
Postoperative mortality (death)
Within six weeks after surgery
Within three months after surgery
Additional surgery rate
One year
Two years
Three years
Four years
Recurrent disc herniation
Complication or other
New condition

1 (0%)
0 (0%)

0.89 ± 0.8

1.2 ± 1.2

<0.001

14 (3%)
1 (0%)
1 (0%)
536 (97%)

10 (4%)
1 (0%)
2 (1%)
233 (95%)

0.34
0.86
0.47
0.23

0 (0%)
3 (1%)
13 (2%)
18 (3%)
516 (94%)

1 (0%)
1 (0%)
5 (2%)
9 (4%)
230 (94%)

0.68
0.77
0.97
0.95
0.99

0 (0%)
1 (0.1%)‡
32 (6%)
40 (7%)
43 (8%)
51 (9%)
32 (6%)
13 (2%)
4 (1%)

0 (0%)
0 (0%)
14 (6%)
24 (10%)
28 (11%)
31 (13%)
17 (7%)
8 (3%)
5 (2%)

0.962
0.235
0.105
0.149

*Includes patients from both the randomized arm and the observational arm. †N = 556 in the nonobese cohort and 250 in the obese cohort. ‡The
values are given as the mean and the standard deviation. §N = 552 in the nonobese cohort and 246 in the obese cohort. #N = 550 in the
nonobese cohort and 246 in the obese cohort.

addition, data for race, center, age, sex, and baseline outcome scores (for SF-36, the
Oswestry Disability Index, the Sciatica Bothersomeness Index, and the Low Back
Pain Bothersomeness Index) were included in the longitudinal regression models.
Secondary and binary outcomes were analyzed with use of generalized estimating
equations that assumed a compound symmetry working correlation structure. The
outcomes were stratified by obesity, and outcomes between these subgroups at
each time point were compared with use of a multiple-degrees-of-freedom Wald
test. Across the four-year duration of follow-up, overall comparisons of areaunder-curve between these subgroups were made with use of a Wald test.
Computations were done with use of SAS procedures PROC MIXED
for continuous data and PROC GENMOD for binary and non-normal sec-

ondary outcomes (SAS version 9.1, Windows XP Pro; SAS Institute, Cary, North
Carolina). Significance was defined as p < 0.05 on the basis of a two-sided
hypothesis test with no adjustments made for multiple comparisons. Such adjustments were not made because the analyses of the current study are not
multiple independent comparisons from which one is looking for a single significant result, but rather consist of the longitudinal assessment over time of
different dimensions of outcomes, including symptoms, function, and disability.

Source of Funding
Funds were received from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (U01-AR45444), the Office of Research on
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Fig. 1

Change in primary outcome measures from baseline following surgical and nonoperative treatment of lumbar intervertebral disc herniation (IDH) in both
obese and nonobese patients.
Women’s Health, the National Institutes of Health, the National Institute of
Occupational Safety and Health, and the Centers for Disease Control and
Prevention. The Multidisciplinary Clinical Research Center in Musculoskeletal
Diseases is funded by NIAMS (P60-AR048094). Funds were used for statistical
analysis and manuscript publication.

Results
n this study of patients with lumbar disc herniation, 854 patients had a BMI of <30 kg/m2 and were defined as nonobese
and 336 patients had a BMI of ‡30 kg/m2 and were defined as
obese. The mean BMI (and standard deviation) was 25.2 ± 2.8
kg/m2 for the nonobese group and 35.0 ± 4.5 kg/m2 for the obese
group (p < 0.001). Differences between the groups at baseline are
noted in the Appendix. Significant demographic differences were
noted between the groups in sex, education, income under
$50,000, and presence of a compensation claim. No significant
difference was observed in the baseline work status of patients
working full or part-time jobs when obese patients (59%) were
compared with nonobese patients (61%) (p = 0.20). Some comorbidities differed significantly between the groups at baseline
(see Appendix). The obese patient group had a higher percentage
of hypertension, diabetes, depression, stomach problems, bowel
problems, and other problems (see Appendix).
Compared with nonobese patients, obese patients had
worse baseline scores for all three primary outcome measures:
the Oswestry Disability Index (52.4 compared with 48.4 points;
p = 0.003), the SF-36 bodily pain domain (25.0 compared with
27.9 points; p = 0.025), and the SF-36 physical function domain (32.5 compared with 39.7 points; p < 0.001). No significant baseline difference was observed between the groups in
the SF-36 mental component summary score. A significantly
higher percentage of obese patients had a preference for surgery

I

compared with nonobese patients (55% compared with 48%;
p = 0.003). Additionally, a significantly higher percentage of
obese patients underwent surgery compared with nonobese
patients (73% compared with 63%; p = 0.002) (see Appendix).
Operative details for those patients managed operatively
are presented in Table I. When compared with nonobese patients, obese patients had a significantly greater operative time
(mean, 86.5 compared with 72.3 minutes; p < 0.001), intraoperative blood loss (mean, 83.2 mL compared with 56.1 mL;
p < 0.001), and length of stay (mean, 1.2 compared with 0.89
day; p < 0.001). No significant differences were observed
between the groups with regard to the incidence of nerve root
injury, wound hematoma, wound infection, perioperative mortality, recurrence, or additional surgery rate.
The changes in primary outcome measures of the operatively managed patients are shown in Figure 1 and Table II.
With regard to the change from baseline function to the fouryear follow-up evaluation in the operative treatment group,
when compared with nonobese patients, obese patients had
significantly less improvement in scores for the SF-36 physical
function (37.3 compared with 47.7 points; p < 0.001), the
SF-36 bodily pain (44.2 compared with 50.0 points; p = 0.005),
and the Oswestry Disability Index (233.7 compared with 240.1
points; p < 0.001). No significant difference between groups was
observed in the change from baseline in the SF-36 mental
component summary score to the four-year follow-up evaluation. At the four-year follow-up evaluation, in the operative
treatment group, when compared with nonobese patients, obese
patients had significantly less improvement in the Sciatica
Bothersomeness Index (210.1 compared with 212.1 points;
p < 0.001) and the Low Back Pain Bothersomeness Index (21.9
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TABLE II Change from Baseline in Primary Outcome Measures of Operatively and Nonoperatively Managed Patients According to BMI
at One, Two, Three, and Four Years of Follow-up Evaluation*†
Change from Baseline
Outcome Scale
Operative treatment group
SF-36 bodily pain‡
Nonobese patients
Obese patients
P value
SF-36 physical function‡
Nonobese patients
Obese patients
P value
SF-36 mental component summary‡
Nonobese patients
Obese patients
P value
Oswestry Disability Index§
Nonobese patients
Obese patients
P value
Nonoperative treatment group
SF-36 bodily pain‡
Nonobese patients
Obese patients
P value
SF-36 physical function‡
Nonobese patients
Obese patients
P value
SF-36 mental component summary‡
Nonobese patients
Obese patients
P value
Oswestry Disability Index§
Nonobese patients
Obese patients
P value

One Year

Two Years

Three Years

Four Years

47.5 ± 1.1
44.7 ± 1.6
0.13

48 ± 1.1
41.3 ± 1.6
<0.001

48.7 ± 1.1
41.7 ± 1.7
<0.001

50.0 ± 1.2
44.2 ± 1.7
0.005

46.2 ± 1
39.8 ± 1.4
<0.001

45.7 ± 1
38.1 ± 1.4
<0.001

46.4 ± 1
38.5 ± 1.5
<0.001

47.7 ± 1.1
37.3 ± 1.6
<0.001

7.7 ± 0.4
7.9 ± 0.6
0.80

6.8 ± 0.4
5.7 ± 0.6
0.17

7 ± 0.4
5.1 ± 0.7
0.022

6.5 ± 0.5
4.9 ± 0.7
0.055

238.5 ± 0.8
235.2 ± 1.2
0.023

239.2 ± 0.8
232.4 ± 1.2
<0.001

239.6 ± 0.8
232.5 ± 1.3
<0.001

240.1 ± 0.9
233.7 ± 1.3
<0.001

34.1 ± 1.4
27.2 ± 2.3
0.008

34.9 ± 1.4
31.2 ± 2.4
0.17

35.8 ± 1.4
27 ± 2.6
0.002

33.4 ± 1.5
30.9 ± 2.6
0.39

31.3 ± 1.2
20.8 ± 2.1
<0.001

32.3 ± 1.3
25 ± 2.2
0.004

33.5 ± 1.3
22 ± 2.3
<0.001

32.0 ± 1.4
23.1 ± 2.4
<0.001

4.4 ± 0.6
4.2 ± 0.9
0.84

4.2 ± 0.6
5.4 ± 1
0.29

4 ± 0.6
4.3 ± 1
0.80

4.6 ± 0.6
3.4 ± 1.1
0.32

225.2 ± 1
216.8 ± 1.7
<0.001

225.6 ± 1
222.3 ± 1.8
0.12

227 ± 1.1
218.9 ± 1.9
<0.001

226.1 ± 1.1
221.4 ± 2
0.034

*The values are given as the mean and the standard error in points. †The values have been adjusted for race, center, age, sex, marital status,
smoking status, compensation, herniation location, working status, depression, other comorbidities (including stroke, diabetes, osteoporosis,
cancer, fibromyalgia, chronic fatigue syndrome, posttraumatic stress disorder, alcohol or drug dependency, hypertension, migraine, anxiety, and
diseases of the heart, lungs, liver, kidneys, blood vessels, nervous system, stomach, or bowels), self-rated health trend, duration of the most
recent episode, treatment preference, and baseline score (for SF-36, the Oswestry Disability Index, the Sciatica Bothersomeness Index, and the
Low Back Pain Bothersomeness Index). ‡The SF-36 scores range from 0 to 100 points, with higher scores indicating less severe symptoms. §The
Oswestry Disability Index ranges from 0 to 100 points, with lower scores indicating less severe symptoms.

compared with 22.3 points; p = 0.011). However, at baseline, no
significant difference was observed in patient satisfaction or selfrated improvement when obese patients were compared with
nonobese patients in the operative treatment group. At the fouryear follow-up evaluation, 77.5% of obese patients and 86.9%
of nonobese patients who had been managed operatively were
working a full or part-time job (p = 0.014) (see Appendix).

The changes in primary outcome measures of the nonoperatively managed patients are reported in Table II. With regard to the change from baseline function to the four-year
follow-up evaluation, when compared with nonoperatively managed nonobese patients, nonoperatively managed obese patients also had significantly less improvement in the SF-36
physical function (23.1 compared with 32.0 points; p = 0.034)
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TABLE III Treatment Effect of Nonobese Patients Compared with Obese Patients for Primary Outcome Measures*
Treatment Effect†
Outcome Scale

One Year

Two Years

Three Years

Four Years

SF-36 bodily pain‡
(points)
Nonobese patients
Obese patients
P value

13.4 (10 to 16.7)
17.5 (12.3 to 22.6)
0.18

13.1 (9.7 to 16.5)
10.2 (4.8 to 15.6)
0.36

12.9 (9.4 to 16.4)
14.7 (8.9 to 20.5)
0.58

16.5 (12.9 to 20.2)
13.3 (7.4 to 19.3)
0.35

SF-36 physical
function‡ (points)
Nonobese patients
Obese patients
P value

14.8 (11.8 to 17.9)
19 (14.4 to 23.7)
0.13

13.4 (10.4 to 16.5)
13.1 (8.3 to 18)
0.91

12.9 (9.7 to 16)
16.5 (11.3 to 21.6)
0.23

15.7 (12.4 to 19)
14.3 (8.9 to 19.6)
0.64

2.5 (1.2 to 3.9)
0.3 (21.9 to 2.5)
0.083

2.9 (1.5 to 4.4)
0.8 (21.5 to 3.1)
0.12

2 (0.5 to 3.4)
1.5 (20.9 to 4)
0.77

213.6 (216.1 to 211.1)
210.1 (214 to 26.2)
0.13

212.7 (215.2 to 210.1)
213.5 (217.8 to 29.3)
0.72

SF-36 mental
component summary‡
(points)
Nonobese patients
Obese patients
P value
Oswestry Disability
Index§ (points)
Nonobese patients
Obese patients
P value

3.3 (1.9 to 4.7)
3.7 (1.6 to 5.8)
0.74

213.3 (215.8 to 210.8)
218.5 (222.2 to 214.7)
0.021

214 (216.7 to 211.3)
212.3 (216.7 to 28)
0.50

*The values are given as the mean, with the 95% confidence interval in parentheses. The values are adjusted for race, center, age, sex, marital
status, smoking status, compensation, herniation location, working status, depression, other comorbidities (including stroke, diabetes, osteoporosis, cancer, fibromyalgia, chronic fatigue syndrome, posttraumatic stress disorder, alcohol or drug dependency, hypertension, migraine,
anxiety, and diseases of the heart, lungs, liver, kidneys, blood vessels, nervous system, stomach, or bowels), self-rated health trend, duration of
most recent episode, treatment preference, and baseline score (for SF-36, the Oswestry Disability Index, the Sciatica Bothersomeness Index, and
the Low Back Pain Bothersomeness Index). †Treatment effect is the difference between the operative and nonoperative mean change from
baseline. Analysis is done with use of a mixed model with a random subject intercept term. Treatment is a time-varying covariate in which the
patient experience prior to surgery is attributed to the nonoperative arm and time is measured from enrollment and the patient postoperative
outcomes are attributed to the operative arm and time is measured from time of surgery. ‡The SF-36 scores range from 0 to 100 points, with
higher scores indicating less severe symptoms. §The Oswestry Disability Index ranges from 0 to 100 points, with lower scores indicating less
severe symptoms.

and the Oswestry Disability Index (221.4 compared with 226.1
points; p < 0.001) scores, but no significant difference in the
SF-36 bodily pain score (30.9 compared with 33.4 points; p =
0.39). No significant difference was observed between groups
in the change from baseline in the SF-36 mental status component score at the four-year follow-up evaluation. No significant
differences were observed in the secondary outcome measures,
including work status, between obese and nonobese patients
who had been managed nonoperatively (see Appendix).
At all follow-up time points and for all primary and
secondary outcome measures, there was a significant treatment
effect, in favor of surgery, in both the obese and nonobese
groups (Table III) (see Appendix). The only exception to this
was the measure of work status (see Appendix), for which the
treatment effect was not significant in obese patients, suggesting that surgery offers no benefit over nonoperative treatment with regard to return to full or part-time work among
obese patients. No significant difference in treatment effect

was observed for any of the primary or secondary outcome
measures when comparing obese and nonobese patients at the
four-year follow-up evaluation (Table III) (see Appendix). This
result suggests that surgery offers a similar benefit over nonsurgical treatment regardless of the patient BMI.
Discussion
he results of the current study demonstrated that obese
patients are more likely to undergo surgical intervention for
lumbar disc herniation than nonobese patients and that obesity
leads to increased operative time, blood loss, and length of
hospital stay. The link between obesity and increased surgical
intervention for lumbar disc herniation has been previously
reported5,30. In two separate cross-sectional studies assessing
>3700 patients, Böstman demonstrated a significant association
between increased BMI and operative treatment of lumbar disc
herniation5,30. Although the explanation of this finding remains
largely unknown, the finding from the current study that obese
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patients have a pretreatment preference for surgery may provide
the answer.
The perioperative findings in this study are at odds with
the medical literature. A prospective study by Andreshak et al.
comparing perioperative findings between obese and nonobese patients undergoing lumbar spine surgery demonstrated no difference in operative time, blood loss, or length of
hospital stay12. The explanation for this difference in findings may be that the present study only included patients
with a diagnosis of lumbar disc herniation and the study by
Andreshak et al.12 evaluated patients with a variety of diagnoses. This discrepancy warrants further investigation because of the known increased risk of infection associated with
these perioperative factors31,32.
We believe that our results largely supported the hypothesis that obesity is associated with worse outcomes after
operative or nonoperative treatment of lumbar disc herniation. At the four-year follow-up evaluation, both operatively
and nonoperatively managed obese patients had significantly
less improvement in the primary outcome measures of the
study. The only exception was the statistically similar improvement from baseline in the SF-36 bodily pain score in
obese and nonobese patients managed nonoperatively. Diseasespecific secondary outcome measures demonstrated a worse
outcome for operatively managed obese patients in the Sciatica
Bothersomeness Index, the Low Back Pain Bothersomeness
Index, and work status. The published data on this topic are
limited and serve to both support and refute the findings of
the current study. In a review of nearly 1100 cases of sciatica
treated nonoperatively, multivariate analysis showed that obesity was associated with adverse six-month outcomes19. More
recently, Cole and Jackson evaluated the use of minimally
invasive techniques to treat lumbar disc herniation in obese
patients and concluded that this minimally invasive approach
is the preferred technique to manage these patients because
of favorable results and a trend toward reduced infectious
complications33.
In the current study, recurrence of disc herniation and
need for additional surgical procedures did not differ significantly between obese and nonobese patients. This finding
contradicts other published literature21. In 2010, Meredith
et al.21 retrospectively reviewed seventy-five patients who had
undergone a microdiscectomy, eight (10.7%) of whom had
experienced a recurrent herniation. Meredith et al. associated
obesity with a twelve times higher likelihood of postoperative
recurrent herniation and a thirty times higher likelihood of
requiring a reoperation and concluded that weight loss counseling should be incorporated in preoperative discussions21.
Because of the small sample size of that previous study, the
findings of our study are likely more representative of the general
population.
The current study advances the literature by identifying
the expected results of operative and nonoperative intervention
in obese patients with the specific diagnosis of symptomatic
lumbar disc herniation. To our knowledge, this study has the
largest series in the literature specific to lumbar disc herniation.
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This study also has the benefit of a prospective design, in which
large samples of geographically diverse patients received treatment at multiple medical centers and were followed for several
years. These attributes served to limit bias, increase the precision of our findings, and provide favorable generalizability of
our results to clinical practice.
There were important methodological limitations to
consider with this as-treated subgroup analysis of data. The
initial SPORT study had been powered to compare operative
treatment with nonoperative treatment for lumbar disc herniation and had not been powered for specific subgroup analyses.
Even though the initial SPORT study22 had not been powered to
detect differences in clinical outcome based on BMI, the current subgroup analysis did detect such differences with significance. Confounding baseline variables in the current study,
including sex, level of education, income, the presence of a
compensation claim, and medical comorbidities, differed between the obese patients and the nonobese patients. These
differences may have affected the results of the present study.
Other limitations included a lack of reassessment of BMI at
specific postoperative time points. In other studies, obese patients had gained an average of 1.5 kg by the twenty-month
average follow-up period34. This reassessment of BMI at specific
postoperative time points would have helped to identify the
effect of surgery on obesity and whether pain from a spine
etiology limits the ability of obese patients to lose weight. Finally, the imprecision of BMI as a marker of obesity was another important limitation. Other measures, such as skin-fold
thickness or body surface area, may be more specific measures
of obesity to include in future studies.
Appendix
Tables showing the patient baseline demographic characteristics, comorbid conditions, clinical findings, and
health status measures, the change from baseline in secondary
outcome measures of operatively managed patients according
to BMI, and the treatment effect of surgery measured by
secondary outcome measures according to BMI are available
with the online version of this article as a data supplement at
jbjs.org. n
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